Chulin Yu

发表

A Bivalent COVID-19 Vaccine Based on Alpha and Beta Variants Elicits Potent and Broad Immune Responses in Mice against SARS-CoV-2 Variants

Yang Wang, Tao Zhang, Meng Chen, 2022, Vaccines.

Development of a thermostable SARS-CoV-2 variant-based bivalent protein vaccine with cross-neutralizing potency against Omicron subvariants

H Zhao, Xiao Zhang, Yu-chang Li, 2022, Virology.

MiR-375 Mediates CRH Signaling Pathway in Inhibiting E2 Synthesis in Porcine Ovary.

Y. Liu, Yue Wang, Chengzhi Yan, 2016, Reproduction.

Protein Inhibitor of Activated STAT Y (PIASy) Regulates Insulin Secretion by Interacting with LIM Homeodomain Transcription Factor Isl1

Di Zhang, Chengzhi Yan, S. Cui, 2016, Scientific Reports.

A Polysaccharide-RBD-Fc-Conjugated COVID-19 Vaccine, SCTV01A, Showed High Immunogenicity and Low Toxicity in Animal Models

Meng Chen, Kuokuo Li, Liangzhi Xie, 2023, Vaccines.

A spike-trimer protein-based tetravalent COVID-19 vaccine elicits enhanced breadth of neutralization against SARS-CoV-2 Omicron subvariants and other variants

Hongpeng Huang, Liangzhi Xie, D. Kong, 2022, Science China Life Sciences.

Preclinical Basis of the Efficacy and Pharmacodynamics of Finotonlimab, a Humanized Anti-PD-1 Monoclonal Antibody with Potent Implications for Clinical Benefit

Liangzhi Xie, Juan Ma, Jing Li, 2023, bioRxiv.

Current status and future directions for the development of human papillomavirus vaccines

Chulin Yu, Rui Wang, Xuefeng Li, 2024, Frontiers in immunology.